Public Policy Resources


As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources


Photo of female cancer patient

Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.

Featured Resources


The Pain & Policy Studies Group (PPSG) at the University of Wisconsin, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) have released a report grading states on their enactment of balanced policies to enhance the delivery of effective pain management

This scorecard evaluates balance between needed access to pain medication for cancer patients and efforts to reduce misuse and abuse of pain medications.

Our brochure helps educate cancer patients and their caregivers about palliative care and its benefits. From where you can find it to how you receive it, the brochure can help cancer patients access this important level of medical care.

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Molecular tests are critical to safe, effective care for cancer patients, yet the oversight system for laboratory developed tests is in need of updating.  This letter, co-signed by 33 organizations, request that Congress act to ensure appropriate diagnostic oversight. 

ACS CAN supports the proposal to allow public databases to serve as a source of evidence to support regulatory demonstration of clinical validity of diagnostic tests.

This report examines the drug development landscape for childhood cancer, identifying scientific, logistical, economic and ethical challenges that are unique to pediatric cancer drug development. 

Photo of ACS CAN Volunteers participating in health care reform Lobby Day event

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

This ACS CAN report focuses specifically on the costs of cancer borne by patients in active treatment as well as survivors.  It examines the factors contributing to the cost of cancer care, the type of direct costs patients pay, and the indirect costs associated with cancer.

Reducing the cancer burden depends on access to meaningful health coverage for all Americans. ACS CAN created an infographic to help illustrate the difference between having access to affordable, adequate coverage and facing barriers to care when facing a cancer diagnosis.

wAmericans who want health insurance but do not have access through a group (like an employer or union) or through a government program (like Medicare or Medicaid) must buy insurance in the individual market.  Current law provides tax credits that help certain individuals purchase this insurance.  The House “American Health Care Act” proposal would dramatically change the tax credits available for purchasing individual market insurance.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

The greatest avoidable known risk factor for skin cancer is avoiding the use of indoor tanning devices. Yet, each year, an estimated 11.3 million Americans engage in indoor tanning. This factsheet discuses ACS CAN's position on tanning devices.

This factsheet discusses the value of screening and how it saves lives. Unfortunately, seniors on Medicare currently are responsible for a 20% coinsurance if a polyp is detected and removed during a screening colonoscopy.

Colorectal cancer is the third most common cancer in men and women, the second leading cause of death in men, and the third leading cause of death in women in the United States.